igel-monitor.de
Evidence-based evaluations of self-pay medical services for patients considering them in Germany
About igel-monitor.de
IGeL-Monitor evaluates the benefits and harms of individual health services that patients pay for themselves in medical practices. It also provides information about these services to help patients make informed decisions.
The project is operated by Medizinischer Dienst Bund, with an interdisciplinary team covering evidence-based medicine and public relations and support from external researchers. Its predecessor, MDS, launched the monitor in 2012; Medizinischer Dienst Bund became its operator in 2022.
Product: A public information service evaluating the benefits and harms of self-pay medical services.
Jobs at igel-monitor.de
More health & medtech companies
IGES
Health systems research and consulting for policymakers, health insurers, providers and healthcare businesses in GermanyNew on EvolcRemote-friendlyIhr Hautarzt - Hautzentrum Ludwigsburg
Dermatology and aesthetic medicine services for patients in Ludwigsburg and nearby areasIhre Zahnärzte Im Medicum Dr. Iris van Husen, Dr. Steffen Thau
Dental care and in-house dental prosthetics for patients in Böblingen, Germanyikk-suedwest.de
Statutory health insurance and healthcare services for members and employers in southwestern Germanyimd-berlin.de
Medical laboratory diagnostics and continuing medical education for physicians, medical practices and patients in Germanyimmanuel.de
Healthcare, social care and support services for patients and communities across GermanySalary transparent
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
